Engine No. 1 LLC Abb Vie Inc. Transaction History

Engine No. 1 LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.6 Million - $1.98 Million	-12,120 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $279,855 - $354,097	2,605 Added 27.38%	12,120 $1.64 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $412,193 - $467,901	3,874 Added 68.68%	9,515 $1.03 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $593,489 - $661,181	5,641 New	5,641 $635,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Engine No. 1 LLC with notifications on news.